Table 1.
Protocols of treatment regimens
| Evaluations | Treatment | |
|---|---|---|
| Pretreatment | Serum β-hCG, complete blood count, liver and kidney function tests, blood type | None |
| Day 1 | Serum β-hCG | MTX (1 mL, 25 mg/mL) local injection guided by ultrasound or UAE with local injection of MTX (1 mL, 25 mg/mL) |
| Day 4 | Serum β-hCG | None |
| Day 7 | Serum β-hCG, ultrasound evaluation | If β-hCG < 15% between days 4 and 7: MTX 50 mg/m2 IM |
| Day 14 | Serum β-hCG, ultrasound evaluation | If β-hCG plateaued or increased: MTX 50 mg/m2 IM |
IM, intramuscular.